Trials / Unknown
UnknownNCT01074424
Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer
Development of a Serum Proteomic Profile for Cervical Cancer With Potential Prognostic Value
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (estimated)
- Sponsor
- Gynecologic Oncology Group · Network
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment. PURPOSE: This research study is looking at biomarkers in blood samples from patients with invasive cervical cancer.
Detailed description
OBJECTIVES: Primary * To develop a serum proteomic profile for cervical cancer using banked pre-treatment serum specimens from patients with invasive cervical cancer and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis. Secondary * To develop a serum proteomic profile for cervical cancer using banked post-treatment serum specimens from these patients and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis. OUTLINE: This is a multicenter study. Banked serum specimens are used to generate proteomic profiles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | proteomic profiling | |
| OTHER | laboratory biomarker analysis |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-03-01
- First posted
- 2010-02-24
- Last updated
- 2010-02-24
Source: ClinicalTrials.gov record NCT01074424. Inclusion in this directory is not an endorsement.